Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 12/20 | 0.38 |
| ▸ | CA1 | P00915 | 9/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethanesulfonic Acid Amide SCHEMBL6507948 | 0.86 | CA2 (0.38) | CA2CA1CA12CA14CA9 | |
| Ethanesulfonic Acid Amide SCHEMBL28038 | 0.84 | — | — | |
| SCHEMBL60402 | 0.84 | — | — | |
| Ethanesulfonic Acid Amide SCHEMBL3480490 | 0.81 | — | — | |
| Ethanesulfonic Acid Amide SCHEMBL9859651 | 0.81 | — | — | |
| Ammonia Solution, Strong SCHEMBL29181623 | 0.81 | — | — | |
| Ethanesulfonic Acid Amide SCHEMBL3402460 | 0.81 | — | — | |
| Ethanesulfonic Acid Amide SCHEMBL2883670 | 0.81 | — | — | |
| Ethanesulfonic Acid Amide SCHEMBL1996587 | 0.81 | — | — | |
| Ethanesulfonic Acid Amide SCHEMBL27416092 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005019191-A2 | 1, 1-DIOXIDO-4H-1,2,4-BENZOTHIADIAZINE DERIVATE UND VERWANDTE VERBINDUNGEN ALS INHIBITOREN DER HCV POLYMERASE ZUR BEHANDLUNG VON HEPATITIS C | ABBOTT LABORATORIES (US) | 2005-03-03 | — | — | WO | disclosed |